Summary. Treatment of pregnant rats with 1 mg indomethacin/kg twice daily i.m. beginning on Day 20 delayed the onset of parturition by about 21 hr and prolonged the duration of spontaneous parturition by 4 hr. Plasma progesterone and oestradiol levels were determined in daily samples of peripheral blood, and uterine contractions were recorded before and during parturition by means of small, chronically implanted intrauterine balloons which were connected to pressure transducers via fluid-filled catheters. Indomethacin treatment did not inhibit or suppress spontaneous or oxytocin-induced contractions, which were of the same intensity in indomethacin-treated as in control rats. Parturition was induced with oxytocin in the same proportion of treated and control rats, but its induction was not successful in treated rats until 1 day later than in controls. The onset of parturition was always related to the plasma progesterone level, which declined at a slower rate in indomethacin-treated than in control rats, reaching baseline values approximately 1 day later in the treated animals. The appearance of 20\g=a\-hydroxysteroiddehydrogenase in the CL of pregnant rats normally occurs on Day 21 of gestation, but activity was not observed until about 1 (0-3) day later in the indomethacin-treated rats, indicating that luteolysis was retarded. Prostaglandin F-2\g=a\infusions given on Day 21 reversed the effects of indomethacin treatment on plasma progesterone, luteal 20\ g=a\ \ x=r eq-\ hydroxysteroid dehydrogenase activity and the timing and duration of parturition, and reduced the high perinatal mortality associated with indomethacin treatment, suggesting that the effects of indomethacin were related to its inhibitory action on prostaglandin synthetase activity. It is concluded that, in rats, indomethacin exerts its effects on parturition through inhibition of luteal regression which was significantly retarded but not prevented, and that indomethacin does not have a direct effect on myometrial contractility.
Introduction
Aspirin, indomethacin and other drugs that inhibit prostaglandin (PG) biosynthesis are known to delay the onset of parturition and prolong its duration in rats (Aiken, 1972; Chester, Dukes, Slater & Walpole, 1972) , rhesus monkeys (Novy, Cook & Manaugh, 1974) and women (Lewis & Schulman, 1973 ;  Collins & Turner, 1975a) , supporting the widely held view (see Karim, 1975) that endogenous PGs are of importance for the normal course of parturition in several species, although their exact role is still obscure.
Parturition is the culmination of a series of events taking place at term, and tissue PGs of placental, uterine or ovarian origin could be involved in several of these events. It has been postulated that uterine PGs contribute significantly to myometrial contractions since aspirin and indomethacin suppress both the synthesis of PGs by and the contractions of the isolated rat uterus in vitro (Aiken, 1972; Vane & Williams, 1973;  Williams, Sneddon & Harney, 1974;  Bauduoin-Legros, Myer & Worcel, 1974) . On the other hand, studies on the effect of PGs on the contractility of the pregnant rat uterus in vivo did not support the hypothesis (Fuchs, 1972) : the sensitivity of the uterus to stimulation by PGE-1, PGE-2 or PGF-2rx diminished markedly at term, and all three compounds failed to induce parturition while oxytocin was highly effective. Uterine contractility in vitro is often different from that observed in the intact organ in vivo (Fuchs & Fuchs, 1963) . The aim of the present investigation was therefore to study the effect of a known PG synthetase inhibitor, indomethacin, on uterine contractility and the response to oxytocin of pregnant rats before and during parturition, as well as to examine its effect on other factors that are of importance for the onset of parturition in this species, such as luteal regression. Plasma progesterone and oestradiol levels were therefore determined, and luteal 20a-hydroxysteroid dehydrogenase (20a-HSD) activity was monitored, since in rats this enzyme is a sensitive indicator of luteolysis (Wiest & Kidwell, 1969) . Preliminary results have already been reported (Fuchs, Smitasiri & Chantaraksri, 1974) .
Indomethacin was chosen as the PG synthetase inhibitor because it is the most potent of the available inhibitors (Flower, 1974) and has been widely used for in vitro and in vivo studies. Although it also inhibits certain other enzymes, notably phosphodiesterase and PG 15-dehydrogenase, the concentrations required are much higher than those inhibiting PG synthetase (Flower, 1974) (PE 20,  o.d. 1-1 mm). Both catheters were passed subcutaneously to the neck of the animals and exteriorized there through a puncture of the skin, as previously described (Fuchs, 1969 (Fuchs & Poblete, 1970 (Fuchs, Mok & Sundaram, 1974) . Control rats received an equal volume (4 ml) of 0-9% (w/v) NaCl. Indomethacin was dissolved in sesame oil and given i.m. twice daily (at 07.30-08.30 and 17.30-18.30 hours) from Day 20.
Blood was collected in ice-cooled, heparinized tubes. Plasma was separated, frozen and kept at -20°C and sent abroad frozen for measurement of progesterone by the radioimmunoassay method of Thorneycroft & Stone (1972) , and of oestradiol by the method of Edqvist & Johansson (1972) . Progesterone was assayed in duplicate samples of 25-50 µ plasma, extracted with 1 ml petroleum ether, using an antiserum raised in rabbits against progesterone-11-succinyl-bovine serum albumin.
Plasma from ovariectomized adrenalectomized rats gave a blank value of < 25 pg. Recovery of added progesterone (250-5000 pg) gave a curve which was superimposable with the standard curve. Oestradiol was measured in duplicate samples of 100 µ plasma, extracted with 1 ml diethyl ether, using an antiserum raised in sheep against oestradiol-17ß-6(0-methyIoxime)-bovine serum albumin, which is highly specific and shows < 11 % cross-reaction with oestrone. The plasma blank had a value of 45 pg. The interassay coefficient of variation was 8 % in both assays, and all values reported are uncorrected for recovery which was over 90 % in both assays.
Histochemical techniques described by Balogh (1964) 
+( (Wiest & Kidwell, 1969) .
The plasma progesterone concentrations obtained in the present study are shown in Table 2 . The values in the morning of Day 20 were more variable than in our previous studies, perhaps reflecting the somewhat heterogeneous rat population used in Bangkok. In the control groups, plasma progesterone fell below 10 ng/ml on the afternoon of Day 22. In oxytocin-infused rats, plasma progesterone decreased more rapidly on Day 21 and had reached lower levels by the morning of Day 22 than in the saline-infused control group, suggesting that oxytocin may have some luteolytic effect, but the differences were not statistically significant. Oxytocin infusions had no effect on the decrease in plasma progesterone in indomethacin-treated rats. The onset of spontaneous and oxytocin-induced parturition was always clearly associated with the fall of plasma progesterone to a level below 10 ng/ml as seen in Table 3 in which the indomethacintreated rats are grouped together according to the course of parturition. 
Oestradiol levels
Oestradiol levels were determined in oil-injected controls (Group 1) and in indomethacin-treated rats given either saline (Group 4) or PGF-2rx on Day 21 (Group 6) (5-8 rats/group). Oestradiol levels varied from 100 to 700 pg/ml without significant differences between control and indomethacintreated animals, although in rats in which parturition was significantly delayed the plasma oestradiol decreased. The mean plasma oestradiol concentration was 270 ± 32 pg/ml on Day 20 in all 3 groups. A moderate increase was observed in control rats in the afternoon of Day 20 which was absent in the indomethacin-treated rats, but due to the large individual variations this difference did not achieve statistical significance. Administration of PGF-2a on Day 21 to the indomethacin-treated rats had no effect on the plasma oestradiol levels.
Ovarian 20a-hydroxysteroid dehydrogenase activity
On Day 20 20a-HSD activity was absent from the ovaries of control and indomethacin-treated rats. On Day 22 the ovaries from 6 control rats exhibited strong activity in all corpora lutea (CL) of pregnancy. Of 9 rats treated with 1 mg/kg indomethacin twice daily, the ovaries of 5 showed no activity, of 2 rats showed weak to moderate activity and of 2 rats showed strong activity, while all CL of rats treated with PGF-2a on Day 21 had strong 20a-HSD activity on Day 22. Inhibition of 20rx-HSD activity on Day 22 by indomethacin was dose dependent, as seen from the results presented in Table 4 . This inhibition was only temporary and 20ot-HSD activity appeared on Day 23 or 24. 
Discussion
The results of the present investigation indicate that the interference with the normal course of parturition observed in indomethacin-treated rats is due to a partial inhibition of luteolysis, prolong¬ ing the secretion of progesterone which normally has ceased by Day 22. In no instance was luteal regression completely prevented, but it is possible that the dose of indomethacin was not sufficient.
A higher dose inhibited the appearance of 20a-HSD activity in the CL more completely but was too toxic for prolonged use. While this work was in preparation, Strauss, Sokolski, Caploe, Duffy & Mintz (1975) reported similar findings on the effect of indomethacin on plasma progesterone in parturient rats. The fact that PGF-2rx, given on Day 21, reversed the effects of indomethacin on plasma proges¬ terone levels and on the activation of luteal 20a-HSD, and restored the subsequent course of parturi¬ tion to normal, strongly suggests that the effects of indomethacin were brought about by inhibition of PG synthetase, although direct proof for this postulate is not provided by these experiments. We have previously shown that the luteolytic effect of PGF-2ot in pregnant rats is always associated with the induction of 20a-HSD activity, and suggested that PGF-2a lowers plasma progesterone by increasing the ovarian conversion of progesterone to 20a-dihydroprogesterone Fuchs & Mok, 1974 (Fuchs, 1974 (Fuchs, ,1975 , but the contractions remain local, and the rapid conduction of contraction waves along the uterine horn seen in oestrogendominated animals is absent. This renders the contractions inefficient for propulsion of the uterine contents, and parturition can proceed normally only when well propagated contractions occur (Csapo, 1969; Fuchs & Poblete, 1970; Fuchs, 1973 synthesis. "The fetus is considered to play an active part in triggering the onset of parturition in many species. Although this has not been demonstrated in the rat, it could be argued that the high incidence of fetal death in itself could have caused the delay in the onset of parturition in indo¬ methacin-treated rats. Since most of the fetal loss occurred in the immediate perinatal period, when parturition was already in progress, this seems unlikely. It has been reported that indomethacin administered to the mother can cause closure of the fetal ductus arteriosus (Sharpe, Thalme & Larsson, 1974) and that PGE-2 and PGF-2a were able to re-open the closed ductus (Sharpe & Larsson, 1975) . Such a mechanism might explain the perinatal deaths observed in the present study. It has recently been demonstrated that the stillbirth rate was significantly increased among women who used aspirin regularly during pregnancy (Collins & Turner, 1975b) . This raises serious questions about the use of indomethacin and other aspirin-like drugs for treatment of premature labour in women.
Although in rats the main effect of indomethacin appears to be inhibition of luteolysis, this mechan¬ ism can hardly be responsible for the prolongation of gestation in primates and it remains to be seen whether uterine contractility, placental hormone production or other factors are influenced by anti-inflammatory drugs in pregnant women.
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